Provide curated and synthetic 10x Flex v2-like single-cell datasets for tool development

Provide curated and synthetic 10x Flex v2-like single-cell datasets for tool development targets a $1.2B = 60,000 research groups and companies × $20K ACV total addressable market with medium saturation and a year-over-year growth rate of 14% CAGR for single-cell sequencing and services (Allied Market Research 2024 estimate).

Key trends driving demand: Single-cell adoption — More labs and pharma teams are using single-cell assays, increasing demand for standardized data for benchmarking and validation.; Synthetic biology and ML tooling — ML-driven synthetic data generation has matured, enabling realistic dataset simulation for testing without legal constraints on human data.; Open-data momentum — Funders and journals increasingly require or encourage data sharing, improving availability of raw data that can be curated into developer-ready bundles..